Toggle light / dark theme

A story from Salon on transhumanism:


While we have a rare combination of candidates with a real chance of taking the White House — a woman, a Jewish socialist and a real estate magnate — there’s another you probably haven’t heard about: a Transhumanist.

Zoltan Istvan, 43, the leader and founder of the Transhumanist party, has entered the race as a third-party candidate promising the “facilitation of immortality.” Istvan, who lives in California, first made headlines when he set out on a cross-country campaign tour in a bus shaped like a hearse last September. His main philosophy: enliven America’s technological advancement by combining humans with machines, to improve and prolong life.

In U.S politics, the two traditional parties have consistently dominated the electorate. In fact, Sen. Bernie Sanders is the only Independent in Congress, every other House member belongs to either the Democratic or Republican Party. But historically the country has had a history of fringe candidates, which typically get a few thousand votes in presidential elections. In 1992, billionaire businessman Ross Perot, who ran on the Reform Party, won 18.9% of the vote, the best finish by a non-major party candidate in a presidential election since Teddy Roosevelt won 27.5% of the vote in 1912. While Perot’s Reform Party, like practically all third parties, has failed to emerge as a contender since then, candidates like him have had a significant impact on electoral outcomes.

Zoltan Istvan is still an ambiguity for most of the political world, and the Transhumanist party in its early stages of development, but there is something to be said about how his policies could predict the way the political landscape might change in the decades to come.

Read more

“I believe our civilization is going to be vastly more intelligent in the decades ahead,” Kurzweil told Time. “You can argue how we got here, but we are the species that goes beyond our limitations. We didn’t stay on the ground. We didn’t stay on the planet. Our species always transcends.”


The famous inventor and tech pundit shares a few words on why he thinks humans will soon live forever.

Read more

Overview.

What is the MMTP? The MMTP is an ambitious project, designed to radically speed up the rate of progress in the field of regenerative medicine and aging research.

The project is the brainchild of our parent organisation, The International Longevity Alliance, a nonprofit foundation for science advocacy and research. The testing and discovery of compounds and treatments to delay or stop the processes of aging is a slow affair, with very few high quality, high impact studies conducted each year.

Read more

The MMTP needs your support!

Have you ever considered your destiny may depend upon, you personally? And beyond that, have you considered the destiny of many others may depend upon your actions? People who have changed the world, didn’t have any doubts that the future depended on their actions. Scientists, businessmen and famous public figures didn’t wait until someone did something important for the world. They took responsibility for what was happening around and acted, despite all the difficulties. Are you ready to become such a person? Maybe you too have always wanted to make a significant difference, but didn’t know where to begin? So spend a moment to read the information below.

Today there is a unique project being prepared by a group of scientists, activists and other like minded people from many countries. A project which will give us the opportunity to rescue millions of people from future suffering. The project brings the fight against aging to a global level. Each day people suffer and die from the many diseases associated with aging. Researchers worldwide are engaged in a valiant effort to save countless lives in the near future.

We are currently preparing the first stage of the MMTP project — to test combinations of geroprotectors on mice. The results of this research will be available to the entire scientific community. It’s a big step in this work against the most serious enemy of mankind — aging and its related diseases. And now our project urgently needs the help of motivated individuals. We’re looking for volunteers who are ready to put in the time and effort, to make a future without aging a reality that much sooner.

We are therefore looking for people with experience in different fields. Our project is greatly in need of the following activists:

Copywriters. Are you able to state your thoughts on set subject well? Are you interested in discoveries in the field of regenerative medicine? Do you have a little time and a lot of desire to participate in something really important? If so we really need you!

Read more

After 10 years of development, the Wake Forest Institute of Regenerative Medicine has finally unveiled a 3D printer that can craft simple tissues, such as cartilage, into complex shapes suitable for implantation.

The printer uses cartridges filled with biodegradable plastic and human cells bound in gel form, and it can grow muscle, cartilage, and even bone. When implanted into animals, these crafted tissues have been shown to survive and even thrive for an indefinite amount of time.

“This is the first [bioprinter] that can print tissue at the large scales relevant for human implantation,” lead scientist behind the project, Anthony Atala, says in the release. “Basically, once we’ve printed a structure, we can keep it alive for several weeks before we implant it. Now the next step is to test these [printed tissues] for safety so we can implant them in the future in patients.”

Read more

A bioprinter – a three dimensional printer that uses living cells in suspension as its ink, and injection nozzles that can follow a CT scan blueprint – brings the dream of transplant surgery a step nearer: a bespoke body part grown in a laboratory and installed by a robot surgeon.

Scientists and clinicians began exploring tissue culture for transplant surgery more than 20 years ago. But researchers in the US report in Nature Biotechnology that they have harnessed a sophisticated, custom-designed 3D printer to print living muscle, cartilage and bone to repair battlefield injury.

The printed body parts so far have been tested only in laboratory animals. But tested organs have the size, structure and function for human use: once transplanted, they could be colonized by blood vessels and begin to grow and renew themselves normally. The study was backed by the US Armed Forces Institute for Regenerative Medicine.

Read more

Researchers say they’ve developed a 3-D bioprinter that can create artificial body parts with ready-made channels for getting nutrients and oxygen to the implanted cells. If the technology can be perfected, the device could solve one of the biggest obstacles to creating 3D-printed organs: how to nourish masses of manufactured tissue.

“It can fabricate stable, human-scale tissue of any shape,” Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine in North Carolina, said in a news release. “With further development, this technology could potentially be used to print living tissue and organ structures for surgical implantation.”

Atala and his colleagues describe their experiments with the bioprinter, known as the Integrated Tissue-Organ Printing System or ITOP, in a study published today by Nature Biotechnology.

Read more


WIKIPEDIA, AYACOP Boosting levels of ghrelin, a hormone involved in hunger, keeps aging-related declines at bay in mice, according to a study published yesterday (February 2) in Molecular Psychiatry.

The authors gave mice a traditional Japanese medicine called rikkunshito or an extract from rikkunshito to stimulate hormone production. In three different mouse lines—two with shortened lifespans and another with a normal lifespan—the treatment resulted in the animals living longer.

“These findings suggest that the elevated endogenous ghrelin signaling has an important role in preventing aging-related premature death,” Akio Inui of Kagoshima University Graduate School of Medical and Dental Sciences and colleagues wrote in their report.

Read more